BioRender 图标

Lymphoblast 1

Lymphoblast 1 - Editable icon of An oval-shaped cell with a large bean-shaped nucleus that takes up most of the space within the cell.
[{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e78/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e78/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e77/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e77/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e76/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e76/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e75/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e75/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e74/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e74/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e73/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e73/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e72/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e72/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e71/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e71/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e70/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e70/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6f/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6f/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6e/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6e/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6d/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6d/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6c/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6c/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6b/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6b/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e6a/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e6a/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e69/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e69/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e68/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e68/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e67/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e67/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e66/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e66/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e65/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e65/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e64/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e64/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e63/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e63/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e62/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e62/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e61/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e61/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e60/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e60/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5f/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5f/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5e/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5e/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5d/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5d/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5c/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5c/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5b/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5b/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e5a/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e5a/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e59/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e59/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e58/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e58/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e57/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e57/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e56/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e56/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e55/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e55/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e54/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e54/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e53/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e53/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e52/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e52/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e51/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e51/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e50/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e50/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4f/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4f/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4e/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4e/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4d/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4d/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4c/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4c/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4b/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4b/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e4a/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e4a/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e49/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e49/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e48/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e48/605a12acc749650026702e46.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/605a131dc749650026702e47/605a12acc749650026702e46.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/605a131dc749650026702e47/605a12acc749650026702e46.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
lymphoblast,leukemic blast,blast,naive lymphocyte,naive,lymphocyte,agnostic leukemia blast cells,myeloblastic leukemia,leukemia,leukaemia,immature,activated,stimulated,big nucleus,large nucleus,acute lymphoblastic leukemia,ALL,peripheral blood,bone marrow,lymphoblast
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Lymphoblast 1 icon JPEG

Lymphoblast 1 icon PNG

Lymphoblast 1 icon SVG

Lymphoblast 1 icon GIF

BioRender 图标常见问题解答

How are scientists using the Lymphoblast 1 icon in their work?

BioRender users often use the Lymphoblast 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Lymphoblast 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Lymphoblast 1 icon customizable in BioRender?

Most icons in BioRender, including the Lymphoblast 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Lymphoblast 1 icon for publication or presentations?

Yes, figures containing the Lymphoblast 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Lymphoblast 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Lymphoblast 1 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Lymphoblast 1 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon